Proposed amendments to British Columbia’s Class Proceedings Act, R.S.B.C. 1996, c.50 (the Act) will permit national opt-out class actions and require the court to consider proceedings in other jurisdictions before agreeing to certify the class action in British Columbia.
April 26, 2018
The Ontario Superior Court of Justice dismissed the defendants’ motion for summary judgment in Apotex’s action for s. 8 damages.
March 20, 2017
In Wise v Abbott Laboratories, Limited, the Ontario Superior Court of Justice granted summary judgment in favour of Abbott Laboratories Ltd., and dismissed the proposed class action alleging AndroGel causes serious cardiovascular events, such as heart attacks and strokes.
December 07, 2016
In a judgment rendered on October 19, 20161, the Quebec Superior Court found for the defendant, Abbott Laboratories Ltd.
November 02, 2016
The Government of Canada has been busy making changes to a number of regulations relating to consumer products.
July 21, 2016
The Winning Combination Inc. marketed a smoking cessation aid in Canada with a confidential active ingredient under the brand name RESOLVE®.
April 29, 2016
The British Columbia Court of Appeal granted Pfizer’s appeal and dismissed the proposed class action.
December 17, 2015
1671183 Ontario Inc. (operating as Pharma Stop) is a wholesaler of pharmaceutical products.
December 08, 2015
The government of British Columbia is seeking public input on a regulation under the pending Franchises Act (Act).
November 20, 2015
The Supreme Court of Canada has granted leave to appeal from two appellate decisions.
November 17, 2015